Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
- 14 March 2003
- journal article
- clinical trial
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (3), 244-248
- https://doi.org/10.1046/j.1365-2362.2003.01130.x
Abstract
Background The treatment of distal ulcerative colitis, refractory to conventional 5‐ASA/steroid treatment, is still a matter of debate. The present study aimed at confirming, with adequate statistica...This publication has 23 references indexed in Scilit:
- Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's diseaseGut, 2000
- Low molecular weight heparin as adjuvant therapy in active ulcerative colitisAlimentary Pharmacology & Therapeutics, 1999
- Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytesGut, 1999
- Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.Gut, 1996
- Review article: Refractory distal colitis-explanations and optionsAlimentary Pharmacology & Therapeutics, 1996
- Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrateDigestive Diseases and Sciences, 1995
- Rectal irrigation with short-chain fatty acids for distal ulcerative colitisDigestive Diseases and Sciences, 1991
- Stimulation of Intestinal Mucosal Growth with Intracolonic Infusion of Short‐Chain Fatty AcidsJournal of Parenteral and Enteral Nutrition, 1989
- THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE?The Lancet, 1980
- Cortisone in Ulcerative ColitisBMJ, 1955